Biotech Firm Avacta Raises £26M To Boost Drug Development
Avacta Group PLC said on Thursday that it has raised £25.7 million ($32.5 million) by issuing shares to investors, giving it a cash boost as the biotechnology company continues the development...To view the full article, register now.
Already a subscriber? Click here to view full article